Press Releases

12 Feb 2026

CUHKMC Stages Phase III Price Adjustment – Streamlining Charging for 24-hour Outpatient and Emergency Services and Launching Outpatient Medication Packages

CUHK Medical Centre (CUHKMC) staged in February 2026 Phase III of its price adjustment initiative, following the former two phases respectively implemented in November and December last year. This phase includes adjusting the charging schemes of 24-hour outpatient and emergency services and outpatient medication: consultation fee is only charged according to the registration time while drug packages are introduced for two common illnesses - upper respiratory tract infection (URTI) and gastroenteritis, with an aim to help patients have a better medical expense budget estimation. The new charging scheme has been soft-launched since 1 February 2026. In the past, consultation fees of our 24-hour outpatient and emergency services varied, based on a bundle of factors, including registration time, whether an appointment was made with a specific doctor, and patient’s conditions (stable or serious). Under the new mechanism, consultation fees are determined only by the registration time. More information of the new charging schemes is available on webpage: https://www.cuhkmc.hk/fees-and-charges/clinical-service-fee/emergency-medicine-centre. To help patients better manage their medical expense budget, after making reference to the past cases of 24-hour outpatient and emergency services and the costs of commonly used medications, CUHKMC has introduced outpatient drug packages for two common illnesses, namely URTI and gastroenteritis, with a three-day package at HK$180 and a five-day package at HK$220. Patients diagnosed with either URTI or gastroenteritis can receive suitable prescriptions from a list of 83 commonly used medications within the relevant drug package. Meanwhile, prices of more than 10 common antibiotics, which are not among the list of drugs covered by the drug packages, have also been adjusted to benefit patients who require antibiotics as part of their treatment. Prices of some charged items in the 24-hour outpatient and emergency services have also been adjusted, including lifting the surcharge on receiving X-ray screening during non-office hours. Ms. Mandy MA, Chief Financial Officer of CUHKMC, said, “Over one-third of the patients using our 24-hour outpatient and emergency services seek treatment for URTI or gastroenteritis. After implementing the time-based charging scheme and drug packages for our 24-hour outpatient and emergency services, patients with mild illnesses such as cold, influenza, or gastroenteritis can clearly and more easily understand their consultation and medication expenses. In addition, the night outpatient consultation fees after 10pm have also been adjusted, so as to help patients lower their expenses for seeking medical assistance late in the night and enable them to receive timely treatment.”

29 Jan 2026

CUHK Medical Centre Marks Fifth Anniversary Launches “History Gallery” Highlighting CUHK’s Medical Education Legacy and Innovation

CUHK Medical Centre (CUHKMC) officially opened in September 2021. To mark its fifth anniversary this year, CUHKMC has established a “History Gallery” on the Lower Ground Floor (LG/F) to showcase the major milestones of The Chinese University of Hong Kong (CUHK), CUHK’s Faculty of Medicine (CU Medicine), and CUHKMC, as well as the synergistic efforts demonstrated among the University, the Faculty of Medicine and the teaching hospital in medical education, training and clinical practice.  The CUHKMC History Gallery traces CUHK’s transformation over more than six decades—from barren hill into today’s university town. It also features precious historical photos from the early years of CU Medicine, including the foundation laying of Choh-Ming Li Basic Medical Sciences Building and medical students attending classes in temporary container classrooms, as well as CU Medicine’s excellent research and clinical strengths. CUHKMC held its Ground Breaking Ceremony in December 2016. The History Gallery presents CUHKMC’s transformation from a car park into a fully-fledged hospital. Many disciplines of CU Medicine are ranked among the top globally. The History Gallery highlights multiple areas of the Faculty’s research excellence already implemented at CUHKMC, including advanced endoscopic therapies, paediatrics allergy, breakthroughs in ophthalmology and visual sciences and lung cancer therapy, as well as innovative technology in medicine and rehabilitation for sports medicine. Dr. CHUNG Kin Lai, Chief Executive Officer of CUHKMC, said, “As a non-profit, private teaching hospital wholly owned by CUHK, CUHKMC works hand in hand with CU Medicine in teaching, research and service, in an inseparable and mutually reinforcing relationship. As CUHKMC enters its fifth anniversary, the newly launched History Gallery is both a retrospective and a forward-looking initiative. We will continue to support the University in translating research excellence into clinical practice, so that medical science and technology can benefit more people in the community. CUHKMC is dedicated to joining hands with CUHK to promote the inheritance and innovation of medical education.”

26 Jan 2026

CUHK Medical Centre and Standard Chartered Establish Exclusive Strategic Partnership Offering Comprehensive Health Consultations for Affluent Clients, Elevating Exclusive Privileges to Selected Priority Private Clients

Standard Chartered Bank (Hong Kong) Limited (Standard Chartered Hong Kong) announced an exclusive strategic partnership with CUHK Medical Centre (CUHKMC) to provide complimentary comprehensive health consultations for Standard Chartered Hong Kong’s affluent clients. The services cover physiotherapy, Chinese medicine treatments, nutrition management, and family medicine specialties, along with a rich array of unique offers on health check ups and designated vaccinations—addressing diverse health needs from prevention to treatment. Eliza LAW, Head of Affluent Segment & Distribution, Standard Chartered Hong Kong, said: “As a leading wealth manager for affluent clients, Standard Chartered is committed to offering one stop banking services and unique experiences that meet clients’ evolving needs. With health and wellness increasing as a priority, we are pleased to become the exclusive partner of the CUHKMC and offer selected clients four complimentary consultations each year. By extending our services beyond traditional banking we are helping our clients enhance both their personal and financial wellness.”  Dr CHUNG Kin Lai, CEO of CUHK Medical Centre, said: “CUHKMC is committed to advancing public health because we believe good health is the cornerstone of a fulfilling life. Our partnership with Standard Chartered Hong Kong goes beyond disease treatment to include rehabilitation, disease prevention, and everyday wellness, reflecting our shared commitment to proactive and personalised healthcare. By bringing together our professional medical expertise and diagnostic capabilities, we aim to support clients in leading healthier lives.” Standard Chartered Hong Kong has recently elevated exclusive privileges to selected Priority Private clients. In addition to the health services, the privileges also cover travel and lifestyle benefits, including access to first class and business class airport lounges, designated local and overseas airport limousine transfers, and the use of premium facilities and dining services at renowned private clubs in Hong Kong.

23 Dec 2025

CUHKMC Stages Phase II Price Adjustment Covering Orthopaedics &Traumatology, Breast Surgery, Gynaecology, Chemotherapy and Chronic Medications

CUHK Medical Centre (CUHKMC) has staged Phase II of its price adjustment initiative on 22 December, extending coverage to Orthopaedics &Traumatology, Breast Surgery, Gynaecology, chemotherapy and chronic medications. Building upon Phase I which commenced on 1 November, this initiative reinforces CUHKMC’s dedication to delivering transparent, affordable and trustworthy medical care. Dr. CHUNG Kin Lai, Chief Executive Officer of CUHKMC, said, “We are pleased to receive positive feedback from the community regarding our Phase I price adjustments. Phase II now extends its coverage, including Orthopaedics &Traumatology, Breast Surgery, Gynaecology, chemotherapy and chronic medications. In this comprehensive review of approximately 320 items, we have implemented price reductions for 76%, maintained current pricing for 21%, with only one item requiring an increase in price.” Many chronic disease patients require long-term medication, including those with hypertension, diabetes, and hyperlipidemia (known as “three-highs”), dementia, and urological conditions. Additionally, chemotherapy treatments typically extend over longer periods, inevitably creating a financial burden through sustained medication costs. To alleviate these medical expenses, in this phase, CUHKMC has reviewed and implemented price reductions for all 100 types of chronic medications and over 120 chemotherapy items, with some prices reducing by up to 30%, demonstrating our commitment to supporting patients throughout their healthcare journey. Taking a patient with “three highs” as an example, their monthly medication expenses have been reduced by approximately 35%, from over $1,800 to about $1,200. In addition to medication costs, fees for the majority of surgical procedures have also been reduced. For example, the fee for bilateral total knee replacement surgery has been reduced by 5.4% from $275,510 to $260,500, i.e. a saving of $15,010. This adjustment initiative encompasses not only price reductions, but also package restructuring across different services. For example, in orthopaedic joint replacement surgery, fees are set according to different brands of artificial joints, with clearer definition of the scope of items covered in the pricing, allowing patients greater flexibility in their choices. For breast surgery, the current package structure has been simplified and some procedures have been unbundled from the existing package to improve charge transparency. Certain gynaecology service fees have been consolidated and repriced to better reflect procedural complexity. In addition, prices for all chemotherapy packages have been reduced in this adjustment exercise.  In Phase I price adjustment implemented last month, over 1,300 items were reviewed, among which over 1,000 items had their fees lowered. In line with Phase I’s principles - prioritising clinical value, implementing evidence-based clinical protocols, and maintaining simple yet flexible pricing structures - CUHKMC provides the public with a wider range of healthcare options at more competitive prices in this phase of price adjustment. On the whole, the price adjustments are based on five key strategies: bottom-up costing, capacity cost rates, complication risk assessment, benchmarking against the market, and factoring in feedback from stakeholders. Through this comprehensive evaluation mechanism, CUHKMC ensures pricing reflects both healthcare value and patient affordability. CUHKMC implementing price adjustments not only provides practical benefits to the public, but also demonstrates CUHKMC’s determination in fulfilling its social responsibilities and serving as a crucial bridge between public and private healthcare systems. CUHKMC will continue to proactively review prices for the public along a practical approach, to ensure service charges are reasonable and value-for-money.

04 Sep 2025

CUHK Medical Centre Receives Donation of Ancient Tree Pu’er Tea for Charity Sale to Support Elderly Dementia Screening; Nearly 30% Diagnosed with Early Alzheimer’s Disease

With a generous donation of premium ancient tree Pu’er tea for charity sale, over HK$340,000 was raised to support CUHK Medical Centre (CUHKMC) in conducting further assessments for elderly individuals suspected of having early dementia. The event, titled “普利眾生” in Chinese, has subsidised 55 elderly people with memory problems to receive the Montreal Cognitive Assessment (MoCA) and blood tests as of August 2025. Among them, 21 participants underwent further evaluation using AccuBrain®, an artificial intelligence (AI) assisted brain imaging assessment tool validated by CUHK. Following the assessment, 16 out of the 55 participants were diagnosed with prodromal or early-stage Alzheimer’s disease, accounting for nearly 30% of the group. Four organisations, namely Po Leung Kuk, Haven of Hope Christian Service, the Hong Kong Buddhist Association and Kwan Sang Charity Foundation Limited, participated in this project. They referred elderly singletons and persons in families of elderly doubletons aged above 60, suspected of early-stage dementia, to CUHKMC for MoCA and blood tests. The blood tests, which are not yet included in routine blood screening at public hospitals, directly measure abnormal proteins in blood, including p-Tau and neurofilament light chain, to aid the diagnosis of dementia. Based on the assessment results, specialists in neurology will arrange the AccuBrain® assessment for those patients who require further evaluation, where the brain MRI scans are analysed with AI technology for detection of dementia. Dr. CHUNG Kin Lai, Chief Executive Officer of CUHKMC, said, “We express our heartfelt gratitude to the generosity of the supporters. Currently, one in every ten elderly people in Hong Kong suffers from dementia, while over 60-80% of dementia patients are diagnosed with Alzheimer’s Disease. CUHKMC and CUHK Faculty of Medicine will continue to work together to advance dementia screening initiatives. We hope to raise public awareness of this disease, enabling early identification and treatment for more patients.” Dr. Alexander LAU Yuk Lun, Specialist in Neurology of CUHKMC, added, “In Hong Kong, among the elderly persons aged 80 or above, one in every five is diagnosed with dementia. The situation is alarming. However, recent research reveals that if we can prevent proactively before symptoms appear, and strengthen our brain health and adjust our lifestyle habits, the incidence rate can be reduced by 40%. Therefore, early prevention, detection and treatment are critical.”

19 Aug 2025

CUHK Medical Centre Launches “Breast Cancer Surgery Subsidy Scheme” Enables Patients Awaiting Designated Breast Cancer Surgeries at Public Hospitals to Receive Timely Treatment

With the generous support of the Lee Yin Yee’s family, CUHK Medical Centre (CUHKMC) launches the “Breast Cancer Surgery Subsidy Scheme” (the Subsidy Scheme) starting from today, enabling 100 patients who are on waiting lists for designated breast cancer surgeries at public hospitals to receive timely treatment. Eligible patients will receive full financial support covering the fees of designated surgery and inpatient hospitalisation, as well as scheduled post-operative surgical outpatient consultations within two months after discharge.  The Subsidy Scheme will be open for application in phases until the quota is full. Applicants must be permanent residents of Hong Kong and have enrolled in the Electronic Health Record Sharing System (eHealth), and who are on waiting lists of one of the following breast cancer surgeries at public hospitals (excluding Breast-Conserving Therapy): Total Mastectomy Total Mastectomy and Sentinel Lymph Node Biopsy and Frozen Section and (if applicable) Axillary Dissection Total Mastectomy and Axillary Dissection Sentinel Lymph Node Biopsy and Frozen Section and (if applicable) Axillary Dissection Axillary Dissection Patients who intend to apply for participation are required to register in advance. Eligible applicants will have to undergo an initial consultation by our designated surgeon for assessing suitability for the designated surgery. More information about the Subsidy Scheme is available on website:   https://www.cuhkmc.hk/hospital-service/medical-centres-allied-health/specialist-outpatient-centre/breast-cancer-surgery-subsidy-scheme Dr. CHUNG Kin Lai, Chief Executive Officer of CUHKMC, expressed his heartfelt gratitude to the Lee Yin Yee’s family for their generous support, which greatly benefits breast cancer patients. “Breast cancer is the most common cancer among females. CUHKMC shoulders the social mission of bridging the service gap between the private and public healthcare systems in Hong Kong. Through our Subsidy Scheme, we aim to assist more public patients awaiting breast cancer surgeries in receiving timely and comprehensive treatment, ultimately improving the treatment outcomes,” Dr. CHUNG said. 

23 Jun 2025

CUHK Medical Centre and HKUST-Nurtured Startup SmartCare Join Forces to Enhance AI-Driven Healthcare Solutions

CUHK Medical Centre (CUHKMC) joins hands with SmartCare Technology Co. Limited (SmartCare), a Healthtech innovator nurtured by The Hong Kong University of Science and Technology (HKUST) to announce a significant partnership aimed at advancing healthcare delivery through innovative artificial intelligence (AI) solutions. The Memorandum of Understanding (MoU) signing ceremony marks a strategic commitment to co-develop AI technology solutions for healthcare settings. This collaboration will harness SmartCare’s expertise in healthcare AI technology and CUHKMC’s commitment to providing exceptional healthcare services. The partnership aims to implement advanced AI technology to enhance clinical workflows, improve patient care, and streamline operational efficiency within CUHKMC’s facilities. Under the MoU, SmartCare, a startup born from HKUST’s Department of Computer Science and Engineering, will provide its cutting-edge AI technology solutions, including a patient-centred consultation platform, while CUHKMC will facilitate access to its AI Lab for the development and integration of these solutions. The collaboration is set to pave the way for the deployment of innovative tools that will transform patient experience and improve healthcare outcomes. Dr. Hong FUNG, Chief Executive Officer of CUHK Medical Centre, said, “The partnership with SmartCare represents our determination to embracing technology that enhances patient care. By integrating AI into our clinical practices, we aim to enhance clinical efficiency, and provide a more personalised and efficient healthcare experience for our patients.” Dr. Justin CHENG, Chief Executive Officer and Co-founder of SmartCare, added, “We are excited to collaborate with CUHKMC to revolutionise healthcare delivery. Our AI-powered solutions are designed to optimise clinical workflows, allowing healthcare providers to focus on what matters most—patient care. Together, we are setting a new standard for innovation in the healthcare sector.” The MoU sets the foundation for further discussions and negotiations on the specifics of the collaboration. Both parties are dedicated to working together in good faith to achieve shared goals that prioritise patient well-being and clinical excellence.

28 Mar 2025

CUHK Medical Centre Announces Appointment of CEO

CUHK Medical Centre (CUHKMC) announces the appointment of Dr CHUNG Kin Lai as the new Chief Executive Officer (CEO) of CUHKMC, with effect from 1 August 2025, succeeding Dr FUNG Hong, who will be retiring and stepping down on 31 July. Dr Chung will assume the role of CEO-designate starting from 16 June to facilitate the handover with Dr Fung. Dr Chung is a specialist in Emergency Medicine by background, and is an experienced senior executive with extensive experience in hospital management. Prior to his current position, he was the Cluster Chief Executive of New Territories East and Hospital Chief Executive (HCE) of Prince of Wales Hospital under the Hospital Authority (HA) since December 2022, overseeing 7 hospitals and medical institutions providing public health services to residents of Shatin, Tai Po and North District. Dr Chung has also served as the HA Director (Quality & Safety), leading various support services for the Government in areas including infection control, disaster emergency response, etc., as well as administering public hospitals’ quality & standards, patient safety, clinical incident management, etc. Dr Chung possesses substantial experience in hospital operation and medical services management, and has shouldered many other important roles including Consultant (Emergency Medicine) of Tuen Mun Hospital, HCE of Castle Peak Hospital and Siu Lam Hospital, and HCE of North District Hospital.  The Board of CUHKMC welcomes Dr Chung as the new CEO of CUHKMC and wishes him every success in his new role. The Board also extends gratitude to Dr Fung for his contributions to the establishment and development of CUHKMC over the past 10 years.  

25 Nov 2024

CUHK Medical Centre Hosts “Innovation Symposium - Pioneering Solutions in Healthcare 2024” To Promote Empathy and Patient Experience

CUHK Medical Centre (CUHKMC) held the “Innovation Symposium - Pioneering Solutions in Healthcare 2024” on 23 November 2024, featuring a series of inspirational panel sessions and talks by distinguished speakers and professionals in healthcare and innovation technology. As the third event after its debut in 2021, this year’s event aims to promote empathy and patient experience, and attracted more than 340 industry leaders and members of the public attending in person and online. In his opening remarks, Dr. Chien LEE, Chairman of the Board of CUHKMC, said, “‘Empathy’ and ‘Innovation’, two seemingly unrelated concepts, are actually intertwined in healthcare. These two elements when properly balanced, lay the foundation for exceptional patient care, ultimately improving patient outcome and experience. When innovators of healthcare grasp the importance of empathy, they will be able to use the rigours of creative thinking to find answers to patients’ challenges.” On 23 November, the symposium consisted of two sessions. In the morning session themed “Empathy and Innovation: The Future of Healthcare”, it featured three panel sessions delivered by eminent medical professionals and innovation technology experts, targeting at professionals in healthcare industry. Mr. Amir Dan RUBIN, CEO of Healthier Capital, shared his insights for leading in patient experience with audience.  Dr. Alexander NG, President of Tencent Healthcare, gave a keynote address on how to encounter the healthcare challenges of the Mainland with a population of 1.4 billion. Ms. LEE Chen Ee, Group Director for Innovation and Transformation of SingHealth, was present to deliver an address on patient-centered innovation. In the afternoon session themed “Care from Heart: Heartwarming Moments between Doctors and Patients”, professors from The Chinese University of Hong Kong as well as CUHKMC specialists and medical professionals hosted 7 health talks covering a vast range of topics, including dementia, cancer treatment, heart disease, etc. Family members of patients were also present to share about their caregiver’s journey. Dr. Hong FUNG, Chief Executive Officer of CUHKMC, said, “Empathy is the key to providing healthcare services. Cultivating empathy is crucial to understanding the needs and feelings of patients and their caregivers. The exchange of knowledge and experience could promote the rationale of empathy and patient experience. That is why we have organised this Symposium, bringing together the industry leaders, innovators and technology experts, to discuss and explore how we could enhance the experience of patients and caregivers in healthcare services.”  On the following day of the Symposium (24 November), an Open House was organised to showcase some of the major services and technologies of CUHKMC to members of the public, including Radiotherapy Centre, Imaging & Interventional Radiology Centre, Cardiology Centre, Endoscopy Centre, Urology Centre, Eye Centre and Wellness Centre. The Open House was attended by around 300 people on the day.